205 related articles for article (PubMed ID: 35113366)
1. Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.
Mirsaeidi M; Baughman RP
Pulm Ther; 2022 Mar; 8(1):43-55. PubMed ID: 35113366
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.
Philbin M; Niewoehner J; Wan GJ
Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550
[TBL] [Abstract][Full Text] [Related]
3. Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
Mirsaeidi M; Baughman RP; Sahoo D; Tarau E
Pulm Ther; 2023 Jun; 9(2):237-253. PubMed ID: 37072607
[TBL] [Abstract][Full Text] [Related]
4. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
[TBL] [Abstract][Full Text] [Related]
5. Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence.
Wan GJ; Niewoehner J; Hayes K
Clinicoecon Outcomes Res; 2023; 15():499-512. PubMed ID: 37397803
[TBL] [Abstract][Full Text] [Related]
6. A Narrative Review of Acthar Gel for the Treatment of Myositis.
Chandra T; Aggarwal R
Rheumatol Ther; 2023 Jun; 10(3):523-537. PubMed ID: 36966453
[TBL] [Abstract][Full Text] [Related]
7. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus.
Askanase AD; Furie RA
Adv Ther; 2022 Jul; 39(7):3088-3103. PubMed ID: 35641860
[TBL] [Abstract][Full Text] [Related]
8. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records.
Chopra I; Qin Y; Kranyak J; Gallagher JR; Heap K; Carroll S; Wan GJ
Ther Adv Respir Dis; 2019; 13():1753466619888127. PubMed ID: 31722624
[TBL] [Abstract][Full Text] [Related]
9. Repository corticotropin for Chronic Pulmonary Sarcoidosis.
Baughman RP; Sweiss N; Keijsers R; Birring SS; Shipley R; Saketkoo LA; Lower EE
Lung; 2017 Jun; 195(3):313-322. PubMed ID: 28353116
[TBL] [Abstract][Full Text] [Related]
10. Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection.
Hayes K; Panaccio MP; Houston P; Niewoehner J; Fahim M; Wan GJ; Dhillon B
Open Access Rheumatol; 2021; 13():315-323. PubMed ID: 34703332
[TBL] [Abstract][Full Text] [Related]
11. Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis.
Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio MP; Wan GJ
J Health Econ Outcomes Res; 2022; 9(1):90-100. PubMed ID: 35529249
[No Abstract] [Full Text] [Related]
12. Acthar
Kaplan J; Askanase A; Chu D; Abdellatif A; Basu D; Mirsaeidi M
Clin Drug Investig; 2023 Oct; 43(10):739-761. PubMed ID: 37792273
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms.
Duchowny MS; Chopra I; Niewoehner J; Wan GJ; Devine B
J Health Econ Outcomes Res; 2021 Jan; 8(1):1-9. PubMed ID: 33521161
[No Abstract] [Full Text] [Related]
14. Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids.
Wynn D; Goldstick L; Bauer W; Zhao E; Tarau E; Cohen JA; Robertson D; Miller A
CNS Neurosci Ther; 2022 Mar; 28(3):364-371. PubMed ID: 34984839
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis.
Hayes K; Niewoehner J; Rice JB; Downes N; Hagopian E; Ma I; Wan GJ
Adv Ther; 2023 Nov; 40(11):4999-5015. PubMed ID: 37728695
[TBL] [Abstract][Full Text] [Related]
16. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
17. Repository Corticotropin Injection (Acthar
Wirta D; McLaurin E; Ousler G; Liu J; Kacmaz RO; Grieco J
Ophthalmol Ther; 2021 Dec; 10(4):1077-1092. PubMed ID: 34669183
[TBL] [Abstract][Full Text] [Related]
18. Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis.
Busch H; Wan GJ; Niewoehner J; Houston P; Su Y; Clinton C; Panaccio MP
Drugs Context; 2022; 11():. PubMed ID: 35382109
[TBL] [Abstract][Full Text] [Related]
19. Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: a pilot, open label study.
Judson MA; Modi A; Ilyas F; Yucel R
Sarcoidosis Vasc Diffuse Lung Dis; 2018; 35(3):192-197. PubMed ID: 32476902
[No Abstract] [Full Text] [Related]
20. Outcomes of Repository Corticotropin Gel for Ocular Sarcoidosis.
Oh DJ; Singh A; Kanu LN; Lobo-Chan AM; MacIntosh PW; Bhat P
Ocul Immunol Inflamm; 2022 Aug; 30(6):1420-1424. PubMed ID: 33826473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]